Elevation of serum riboflavin carrier protein in breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 11, 1999, Pages 985-990

  Rao, Prakash N ^a   Levine, Edward ^a   Myers, Michael O ^a   Prakash, Veena ^a   Watson, James ^a   Stolier, Alan ^a   Kopicko, Jeffrey J ^a   Kissinger, Patricia ^a   Raj, Shailaja G ^a   Raj, Madhwa H G ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SINGLE BLIND PROCEDURE;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROADENOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0032718104     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Berg, J. W., and Hutter, R. V. Breast cancer. Cancer (Phila.), 75 (Suppl.): 257-269 1997.
2. Adiga, P. R., Viswesraiah, S. S., and Karande, A., and Velu, N. K. Biochemical and immunological aspects of riboflavin carrier protein. J. Biosci. (Bangalore), 13: 87-104, 1988.
3. Adiga, P. R., Karande, A. A., Viswesraiah, S., and Seshagiri, P. B. Carrier protein mediated transplacental riboflavin transport in the primate. In: N. R. Moudgal, K. Yoshinaga, A. J. Rao, and P. R. Adiga (eds), Perspectives in Primate Reproductive Biology, pp. 129-140. New Delhi: Wiley Eastern, 1991.
4. Zeng, D. B., Lin, H. M., Pene, J. J., and White, H. B. Chicken riboflavin binding protein: cDNA sequence and homology with folate binding protein. J. Biol. Chem., 263: 11126-11129, 1988.
5. Holm, J., Hansen, S. I., Sondergaard, K., and Madwen, M. H. The high affinity folate binding protein in normal and malignant mammary gland tissue. In: J. E. Ayling (ed), Chemistry and Biology of Pteridines and Folates, pp. 757-760. New York: Plenum Press, 1993.
6. Raj, S. G., Nair, S., Mastorakos, G., and Nelson, L. M. Anamnestic development of lymphocytic infiltration in murine experimental autoimmune oophoritis is primarily localized in the stroma and theca. Am. J. Reprod. Immunol. 341: 25-31, 1995.
7. Rosner, B. Fundamentals of Biostatistics. Boston: Duxbury Press, 1986.
8. Byrt, T., Bishop, J., and Carlin J. Bias, prevalence and κ. J. Clin. Epidemiol., 45: 423-429, 1993.
9. Zweig, M., and Campbell G. Receiver-operating characteristic (ROC) plots. A fundamental evaluation tool in clinical medicine. Clin. Chem., 39: 561-577, 1993.
10. Natraj, U., George, S., and Kadam P. Isolation and partial characterization of human riboflavin carrier protein and the estimation of its levels during human pregnancy. J. Reprod. Immunol., 13: 1-5, 1988.
11. Donegan, W. L. Evaluation of a palpable breast mass. N. Engl. J. Med., 327: 937-942, 1992.
12. Ciatto, S., Cataliotti, L., and Distante V. Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology, 165: 99-102, 1987.
13. Elmore J., G., Barton, M. B., Moceri, V. M., Polks, Arena, P. J., and Fletcher, S. W. Ten year risk of false positive screening mammograms and clinical breast examinations. N. Engl. J. Med., 338: 1089-1096, 1998.
14. Ramesh Babu, P. B., and Meenakshi, A. Evidence for estrogen induced riboflavin carrier protein in sera of human breast cancer: Its correlation with estrogen receptor status. Med. Sci. Res., 24: 37-39, 1995.